Alexion Clinical Trial

Alexion is now recruiting for copper and Molybdenum Balance in Participants with Wilson disease treated with ALXN 1840.

Click here for more information, or click here for a brochure about the trial.

By Published On: June 22, 2021Categories: Clinical Trials

Share This Story, Choose Your Platform!